DrugCite
Search

COSOPT

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Cosopt Adverse Events Reported to the FDA Over Time

How are Cosopt adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Cosopt, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Cosopt is flagged as the suspect drug causing the adverse event.

Most Common Cosopt Adverse Events Reported to the FDA

What are the most common Cosopt adverse events reported to the FDA?

Intraocular Pressure Increased
82 (3.88%)
Drug Ineffective
47 (2.22%)
Eye Irritation
43 (2.04%)
Eye Pain
37 (1.75%)
Ocular Hyperaemia
36 (1.7%)
Dyspnoea
29 (1.37%)
Eye Disorder
28 (1.33%)
Visual Acuity Reduced
27 (1.28%)
Vision Blurred
25 (1.18%)
Bradycardia
22 (1.04%)
Glaucoma
22 (1.04%)
Show More Show More
Syncope
20 (.95%)
Headache
17 (.8%)
Blindness
16 (.76%)
Conjunctivitis
16 (.76%)
Cough
16 (.76%)
Dizziness
16 (.76%)
Blindness Unilateral
15 (.71%)
Death
15 (.71%)
Eye Pruritus
15 (.71%)
Pain
15 (.71%)
Convulsion
14 (.66%)
Decreased Appetite
14 (.66%)
Depression
14 (.66%)
Drug Hypersensitivity
14 (.66%)
Lacrimation Increased
14 (.66%)
Adverse Event
13 (.62%)
Cataract
13 (.62%)
Drug Exposure During Pregnancy
13 (.62%)
Hypokalaemia
13 (.62%)
Hypotension
13 (.62%)
Cardiac Disorder
12 (.57%)
Hypersensitivity
12 (.57%)
Hyponatraemia
12 (.57%)
Intraocular Pressure Fluctuation
12 (.57%)
Leukaemia
12 (.57%)
Product Substitution Issue
12 (.57%)
Thyroid Cancer
12 (.57%)
Electrocardiogram Qt Prolonged
11 (.52%)
Erythema
11 (.52%)
Growth Of Eyelashes
11 (.52%)
Tachycardia
11 (.52%)
Drug Interaction
10 (.47%)
Heart Rate Irregular
10 (.47%)
Loss Of Consciousness
10 (.47%)
Blindness Transient
9 (.43%)
Drug Rash With Eosinophilia And Sys...
9 (.43%)
Dysgeusia
9 (.43%)
Eye Swelling
9 (.43%)
Myocardial Infarction
9 (.43%)
Nausea
9 (.43%)
Paraesthesia
9 (.43%)
Visual Impairment
9 (.43%)
Abdominal Pain
8 (.38%)
Asthma
8 (.38%)
Chest Pain
8 (.38%)
Circumstance Or Information Capable...
8 (.38%)
Corneal Oedema
8 (.38%)
Drug Prescribing Error
8 (.38%)
Dry Eye
8 (.38%)
Erythema Of Eyelid
8 (.38%)
Palpitations
8 (.38%)
Retinal Vein Occlusion
8 (.38%)
Sinusitis
8 (.38%)
Tinnitus
8 (.38%)
Visual Field Defect
8 (.38%)
Abnormal Dreams
7 (.33%)
Angioedema
7 (.33%)
Burning Sensation
7 (.33%)
Drug Dose Omission
7 (.33%)
Fall
7 (.33%)
Fatigue
7 (.33%)
Hypoaesthesia
7 (.33%)
Intraocular Pressure Test Abnormal
7 (.33%)
Nasal Congestion
7 (.33%)
Product Dropper Issue
7 (.33%)
Swelling Face
7 (.33%)
Abortion Spontaneous
6 (.28%)
Atrial Fibrillation
6 (.28%)
Blood Cholesterol Increased
6 (.28%)
Blood Glucose Increased
6 (.28%)
Cardio-respiratory Arrest
6 (.28%)
Choroid Melanoma
6 (.28%)
Diarrhoea
6 (.28%)
Drug Intolerance
6 (.28%)
Eye Burns
6 (.28%)
Eye Discharge
6 (.28%)
Fear
6 (.28%)
Hypertension
6 (.28%)
Oropharyngeal Discomfort
6 (.28%)
Penile Pain
6 (.28%)
Photosensitivity Reaction
6 (.28%)
Pleurisy
6 (.28%)
Product Container Issue
6 (.28%)
Product Quality Issue
6 (.28%)
Pruritus Generalised
6 (.28%)
Weight Decreased
6 (.28%)
Accidental Overdose
5 (.24%)
Asthenia
5 (.24%)
Blood Pressure Abnormal
5 (.24%)
Cerebrovascular Accident
5 (.24%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Cosopt, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cosopt is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Cosopt

What are the most common Cosopt adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Cosopt, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cosopt is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Cosopt According to Those Reporting Adverse Events

Why are people taking Cosopt, according to those reporting adverse events to the FDA?

Glaucoma
633
Intraocular Pressure Increased
72
Drug Use For Unknown Indication
69
Product Used For Unknown Indication
64
Open Angle Glaucoma
40
Ocular Hypertension
22
Show More Show More
Developmental Glaucoma
14
Intraocular Pressure Test
10
Ill-defined Disorder
9
Eye Disorder
8
Uveitis
8
Cataract
6
Normal Tension Glaucoma
5
Infection
5
Angle Closure Glaucoma
4
Intraocular Pressure Test Abnormal
4
Macular Degeneration
3
Keratoconus
2
Hypertonia
2
Extraocular Muscle Disorder
2
Retinal Detachment
2
Myelodysplastic Syndrome
2
Drug Exposure During Pregnancy
2
Inflammation
2
Prophylaxis
2
Detached Retina Repair
1
Blindness Unilateral
1
Eye Infection Toxoplasmal
1
Corneal Transplant
1
Blindness
1
Retinopathy
1
Post Procedural Complication
1
Dry Eye
1
Retinal Disorder
1
Corneal Erosion
1
Cataract Operation
1
Glaucoma Drug Therapy
1
Hypertension
1
Erythropsia
1

Drug Labels

LabelLabelerEffective
CosoptPhysicians Total Care, Inc.05-MAY-10
Cosopt PfMerck Sharp & Dohme Corp.24-MAY-12
CosoptMerck Sharp & Dohme Corp.16-NOV-12

Cosopt Case Reports

What Cosopt safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Cosopt. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Cosopt.